Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Trader J who wrote (2018)	12/14/1998 11:24:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 56535

Not for daytrading... If you get a chance, could you take a quick look at the chart for ctic? Is it under accumulation? ...I owned this once at $2, and then sold as I learned just how much competition there is in the Taxol area, but now I am back in. (Cell Ther. has an exclusive worldwide license to the rights to polyglutamic acid paclitaxel ("PG-TXL") a water-soluble form of the cancer drug, Taxol) I am getting interested again, mainly because of their work in the area of GvHD biz.yahoo.com anyway, for biofreaks out there, this one seems to be under accumulation (although I am not much of a chart reader). I repurchased the shares I gave up awhile ago, might be worth a look--something to roll those daytrading profits into for a long-term hold. Oh, they also have this... biz.yahoo.com --MM